Moderna, Inc. (NASDAQ:MRNA) President Stephen Hoge filed a Form 4 on September 3, 2026, disclosing the vesting of restricted stock units and a related tax-withholding share disposition dated September 1, 2026.

Key Highlights

  • RSU conversion: 9,283 restricted stock units converted into 9,283 shares of common stock on a one-for-one basis on September 1, 2026 (transaction code M).
  • Shares withheld for taxes: 4,489 shares were disposed of (transaction code F) at $140.34 per share to satisfy tax withholding obligations connected to the RSU vest.
  • Direct ownership after transactions: Hoge directly held 1,489,699 shares of common stock following the reported transactions.
  • Remaining RSUs: 92,828 restricted stock units remain directly held by Hoge after the reported activity.
  • Indirect holdings: 4,116 shares are held indirectly through Valhalla, LLC, and 151,933 shares are held indirectly through a trust for the benefit of Hoge's spouse and children.
  • Vesting schedule: 25% of the RSU award vested on March 1, 2026, with the remainder vesting in twelve equal quarterly installments thereafter, according to the filing.

Details of Hoge's RSU Vest and Share Disposition at Moderna

According to the Form 4 filed with the SEC, Stephen Hoge, President of Moderna, Inc., reported two transactions in common stock on September 1, 2026. First, 9,283 restricted stock units were converted into an equivalent number of common shares (transaction code M), increasing his directly held position to 1,494,188 shares. The filing notes that restricted stock units convert into common stock on a one-for-one basis.

Immediately following that conversion, 4,489 shares were withheld at a price of $140.34 per share under transaction code F. The filing states this represents "shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units." After this disposition, Hoge's direct beneficial ownership stood at 1,489,699 shares of common stock.

In Table II of the filing, Hoge's remaining derivative security position is reported at 92,828 restricted stock units held directly. Regarding indirect holdings, 4,116 shares are held through Valhalla, LLC, and 151,933 shares are held through a trust of which Hoge's spouse is a trustee and which benefits Hoge's spouse and children. The filing states that Hoge "disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any." The Form 4 was signed by James Dillon as Attorney-in-Fact on September 3, 2026.

What Was Disclosed

The filing disclosed the vesting of 9,283 RSUs into common shares and the withholding of 4,489 shares at $140.34 to cover taxes, leaving Moderna President Stephen Hoge with direct ownership of 1,489,699 common shares and 92,828 remaining RSUs.